CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.39 From SG$0.36, Keeps at Add
CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.39 From SG$0.36, Keeps at Add
CGS-CIMB將Hyphens Pharma的目標股價從0.36新加坡元調整爲0.39新加坡元，保持漲幅
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊